O N THE
MIT Sloan School of Management
The Massachusetts Institute of Technology
The 2005 Executive Summit on Corporate Risk
Addressing 21 st Century GMPs:
2003 The Future of The Pharmaceutical Industry
December 9 - 10, 2003 Pharmacogenomics, Drug Development and the Cost of Health Care, A Special One-and-a-Half Day Program for Senior Corporate Management, Massachusetts Institute of Technology, Sloan School of Management, Tang Center, Wong Auditorium, Cambridge, Massachusetts
New technologies are shifting the terrain of drug discovery and development. The world of healthcare is undergoing the first part of a major revolution. But will the tremendous advances in science and technology that have unfolded in recent years serve the goal of greater human health? What are the key challenges and issues facing scientists and the pharmaceutical industry? What might the future look like?
° Symposium Brochure
° Revised Agenda (as of November 5, 2003)
° Guest Speakers
° For more information about this event, click on post card or contact Abby Votto with your name, title, company, mailing address, telephone and fax to: (508) 616-5533 or e-mail to email@example.com.
° Conference Registration
° MIT Office of Corporate Relations/Industrial Liaison Program
Attn: Conference Planning
292 Main Street, E38-500
Cambridge, MA 02139
For questions regarding your registration for this conference or up-to-the-minute information about this conference, please contact Diane Vrattos at (617) 253-0414 or send e-mail to: firstname.lastname@example.org.
If you do not have the free Adobe Acrobat Reader, click here
2001 The Future of The Pharmaceutical Industry
December 13-14, 2001 Integrating New Drug Discovery & Development Technology
with Complex Biological Systems Research, A Special One-and-a-Half Day Program for Senior Corporate
Management, Cambridge, Massachusetts
Scientific and technological advances are making information about cellular mechanisms of
disease available at an unprecedented rate. How is this information being converted into
therapeutic knowledge? What are the implications for developing therapeutic solutions on a
complex, biological, systems scale, for measuring drug effects and for predicting outcomes?
° Download Brochure
° Symposium Agenda
1999 The Future of The Pharmaceutical Industry
1997 The Future of The Pharmaceutical Industry
For more information, comments, or suggestions contact
Sloan School of